MedPath

Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.

Not Applicable
Recruiting
Conditions
Pain, Postoperative
Cesarean Section Complications
Registration Number
NCT06324942
Lead Sponsor
University of Calgary
Brief Summary

The purpose of this research study is to evaluate whether or not adding a Transversus Abdominis Plane Block (TAP block) improves pain control for patients having a cesarean section. A TAP block is a type of nerve block where at the end of the surgery an injection of a long acting local anesthetic is made into the abdominal wall. In studies in patient's having other abdominal surgeries this has reduced the amount of narcotics patients need for pain control. This may also led to patients being more active after surgery and maybe spending less time in hospital.

Detailed Description

Randomized clinical trial of Transversus Abdominis Plane Block (TAP block) at Cesarean Section.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • ASA status II to III
  • All patients undergoing elective CS under regional anesthesia at any gestational age.
Exclusion Criteria
    • Known drug allergy to local anesthetics
  • Planned general anesthetic
  • NSAID use contraindicated post partum
  • Chronic pain disorder or chronic narcotic use/dependence
  • Planned vertical abdominal incision
  • Planned Cesarean Hysterectomy.
  • Placenta Previa or suspected Placenta Accreta

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Post operative Pain12 hours post op

VAS scale 0-no pain to 10-worst pain

Secondary Outcome Measures
NameTimeMethod
Time to first request for rescue analgesia in hours48 hours post op

Time from completion of surgery to first request for rescue analgesia in hours

Time from surgery to discharge from hospitalUp to discharge from hospital, usually 1-3 days

Time from completion of surgery to discharge

Post operative Opioid useup to 48 hours post op.

Total opioid consumption in the first 24h and 48h mark, postoperatively

Trial Locations

Locations (1)

University of Calgary

🇨🇦

Calgary, Alberta, Canada

University of Calgary
🇨🇦Calgary, Alberta, Canada
Stephen Wood, MD
Contact
403-944-1438
stephen.wood@albertahealthservices.ca

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.